ProQR Therapeutics (PRQR) Total Debt (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Total Debt for 5 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 15.83% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, up 15.83% year-over-year, with the annual reading at $5.7 million for FY2025, 15.83% up from the prior year.
  • Total Debt hit $5.7 million in Q4 2025 for ProQR Therapeutics, up from $4.9 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $50.4 million in Q4 2021 to a low of $4.6 million in Q4 2023.
  • Historically, Total Debt has averaged $14.5 million across 5 years, with a median of $5.7 million in 2025.
  • Biggest five-year swings in Total Debt: plummeted 86.3% in 2022 and later grew 15.83% in 2025.
  • Year by year, Total Debt stood at $50.4 million in 2021, then tumbled by 86.3% to $6.9 million in 2022, then crashed by 33.15% to $4.6 million in 2023, then rose by 6.03% to $4.9 million in 2024, then rose by 15.83% to $5.7 million in 2025.
  • Business Quant data shows Total Debt for PRQR at $5.7 million in Q4 2025, $4.9 million in Q4 2024, and $4.6 million in Q4 2023.